157 related articles for article (PubMed ID: 30935796)
1. The synthesis of 4,6-diaryl-2-pyridones and their bioactivation in CYP1 expressing breast cancer cells.
Ruparelia KC; Lodhi S; Ankrett DN; Wilsher NE; Arroo RRJ; Potter GA; Beresford KJM
Bioorg Med Chem Lett; 2019 Jun; 29(11):1403-1406. PubMed ID: 30935796
[TBL] [Abstract][Full Text] [Related]
2. The Synthesis of Chalcones as Anticancer Prodrugs and their Bioactivation in CYP1 Expressing Breast Cancer Cells.
Ruparelia KC; Zeka K; Ijaz T; Ankrett DN; Wilsher NE; Butler PC; Tan HL; Lodhi S; Bhambra AS; Potter GA; Arroo RRJ; Beresford KJM
Med Chem; 2018; 14(4):322-332. PubMed ID: 29332599
[TBL] [Abstract][Full Text] [Related]
3. Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1-mediated metabolism to the product 4' hydroxy tangeretin.
Surichan S; Arroo RR; Tsatsakis AM; Androutsopoulos VP
Toxicol In Vitro; 2018 Aug; 50():274-284. PubMed ID: 29626627
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 CYP1 metabolism of hydroxylated flavones and flavonols: Selective bioactivation of luteolin in breast cancer cells.
Wilsher NE; Arroo RR; Matsoukas MT; Tsatsakis AM; Spandidos DA; Androutsopoulos VP
Food Chem Toxicol; 2017 Dec; 110():383-394. PubMed ID: 29097115
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism.
Androutsopoulos V; Arroo RR; Hall JF; Surichan S; Potter GA
Breast Cancer Res; 2008; 10(3):R39. PubMed ID: 18454852
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 isoforms 1A1, 1B1 AND 2W1 as targets for therapeutic intervention in head and neck cancer.
Presa D; Khurram SA; Zubir AZA; Smarakan S; Cooper PA; Morais GR; Sadiq M; Sutherland M; Loadman PM; McCaul J; Shnyder SD; Patterson LH; Pors K
Sci Rep; 2021 Sep; 11(1):18930. PubMed ID: 34556703
[TBL] [Abstract][Full Text] [Related]
7. CYP enzymes, expressed within live human suspension cells, are superior to widely-used microsomal enzymes in identifying potent CYP1A1/CYP1B1 inhibitors: Identification of quinazolinones as CYP1A1/CYP1B1 inhibitors that efficiently reverse B[a]P toxicity and cisplatin resistance.
Sonawane VR; Siddique MUM; Gatchie L; Williams IS; Bharate SB; Jayaprakash V; Sinha BN; Chaudhuri B
Eur J Pharm Sci; 2019 Apr; 131():177-194. PubMed ID: 30776468
[TBL] [Abstract][Full Text] [Related]
8. Diaryl triazenes inhibit cytochrome P450 1A1 and 1B1 more strongly than aryl morpholino triazenes.
Moran R; Nakamura R; Isovitsch R; Iimoto D
Bioorg Med Chem Lett; 2022 Mar; 59():128570. PubMed ID: 35063631
[TBL] [Abstract][Full Text] [Related]
9. Identification of leads for antiproliferative activity on MDA-MB-435 human breast cancer cells through pharmacophore and CYP1A1-mediated metabolism.
Nandekar PP; Khomane K; Chaudhary V; Rathod VP; Borkar RM; Bhandi MM; Srinivas R; Sangamwar AT; Guchhait SK; Bansal AK
Eur J Med Chem; 2016 Jun; 115():82-93. PubMed ID: 26994845
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of pyrrole-based chalcones as CYP1 enzyme inhibitors, for possible prevention of cancer and overcoming cisplatin resistance.
Williams IS; Joshi P; Gatchie L; Sharma M; Satti NK; Vishwakarma RA; Chaudhuri B; Bharate SB
Bioorg Med Chem Lett; 2017 Aug; 27(16):3683-3687. PubMed ID: 28711350
[TBL] [Abstract][Full Text] [Related]
11. Anticancer evaluation of some newly synthesized N-nicotinonitrile derivative.
Shamroukh AH; El-Shahat M; Drabowicz J; Ali MM; Rashad AE; Ali HS
Eur J Med Chem; 2013 Nov; 69():521-6. PubMed ID: 24095746
[TBL] [Abstract][Full Text] [Related]
12. α-naphthoflavone-derived cytochrome P450 (CYP)1B1 degraders specific for sensitizing CYP1B1-mediated drug resistance to prostate cancer DU145: Structure activity relationship.
Chen P; Wang S; Cao C; Ye W; Wang M; Zhou C; Chen W; Zhang X; Zhang K; Zhou W
Bioorg Chem; 2021 Nov; 116():105295. PubMed ID: 34455300
[TBL] [Abstract][Full Text] [Related]
13. Nitidine Chloride-Induced CYP1 Enzyme Inhibition and Alteration of Estradiol Metabolism.
Mao X; Wang J; Wang Q; Yang L; Li Y; Lin H; Peng Y; Zheng J
Drug Metab Dispos; 2019 Aug; 47(8):919-927. PubMed ID: 31147316
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel 2'-hydroxy group substituted 2-pyridone derivatives as anticancer agents.
Lv Z; Zhang Y; Zhang M; Chen H; Sun Z; Geng D; Niu C; Li K
Eur J Med Chem; 2013 Sep; 67():447-53. PubMed ID: 23920246
[TBL] [Abstract][Full Text] [Related]
15. Aryl morpholino triazenes inhibit cytochrome P450 1A1 and 1B1.
Lee D; Perez P; Jackson W; Chin T; Galbreath M; Fronczek FR; Isovitsch R; Iimoto DS
Bioorg Med Chem Lett; 2016 Jul; 26(14):3243-3247. PubMed ID: 27265259
[TBL] [Abstract][Full Text] [Related]
16. Metformin suppresses CYP1A1 and CYP1B1 expression in breast cancer cells by down-regulating aryl hydrocarbon receptor expression.
Do MT; Kim HG; Tran TT; Khanal T; Choi JH; Chung YC; Jeong TC; Jeong HG
Toxicol Appl Pharmacol; 2014 Oct; 280(1):138-48. PubMed ID: 25110054
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Anti-Breast Cancer Activity, and Molecular Docking Study of a New Group of Acetylenic Quinolinesulfonamide Derivatives.
Marciniec K; Pawełczak B; Latocha M; Skrzypek L; Maciążek-Jurczyk M; Boryczka S
Molecules; 2017 Feb; 22(2):. PubMed ID: 28212337
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel 1,6-diaryl pyridin-2(1H)-one analogs.
Chen T; Luo Y; Hu Y; Yang B; Lu W
Eur J Med Chem; 2013 Jun; 64():613-20. PubMed ID: 23708235
[TBL] [Abstract][Full Text] [Related]
19. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates estradiol-induced aldehydic DNA lesions in human breast cancer cells through alteration of CYP1A1 and CYP1B1 expression.
Chen ST; Chen DR; Fang JP; Lin PH
Breast Cancer; 2015 May; 22(3):269-79. PubMed ID: 23700305
[TBL] [Abstract][Full Text] [Related]
20. 4-(3-Alkyl-2-oxoimidazolidin-1-yl)-N-phenylbenzenesulfonamides as new antimitotic prodrugs activated by cytochrome P450 1A1 in breast cancer cells.
Chavez Alvarez AC; Zarifi Khosroshahi M; Côté MF; Gagné-Boulet M; Fortin S
Bioorg Med Chem; 2018 Oct; 26(18):5045-5052. PubMed ID: 30201525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
